Retinopatía por hidroxicloroquinanuevas evidencias y recomendaciones

  1. Rodríguez Ferrer, José Manuel 1
  2. Sáez Moreno, José Antonio 2
  3. Rodríguez Hurtado, Francisco Jorge 3
  1. 1 Universidad de Granada
    info

    Universidad de Granada

    Granada, España

    ROR https://ror.org/04njjy449

  2. 2 Hospital Universitario San Cecilio
    info

    Hospital Universitario San Cecilio

    Granada, España

  3. 3 Hospital Universitario Virgen de las Nieves
    info

    Hospital Universitario Virgen de las Nieves

    Granada, España

    ROR https://ror.org/02f01mz90

Erakutsi afiliazioak +
Aldizkaria:
Actualidad médica

ISSN: 0365-7965

Argitalpen urtea: 2014

Liburukia: 99

Zenbakia: 792

Orrialdeak: 85-91

Mota: Artikulua

DOI: 10.15568/AM.2014.792.RE01 DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Actualidad médica

Laburpena

Hydroxychloroquine retinopathy, although affects a small number of people treated with it, has the importance that can produce permanent visual loss and interruption of its administration is the only management of the toxicity. After cessation of the treatment there is little if any visual recovery. Therefore, early detection of retinopathy, when the retinal alterations can be reversed, is essential and a current challenge of medicine. Imaging techniques as the fundus autofluorescence and spectral domain-optical coherence tomography and functional exploration of the retina by the multifocal electroretinogram show new objective morphological and functional alterations induced by hydroxychloroquine. This review details the main findings obtained with these techniques and their impact on the current concepts of the issue and its prevention.

Datuen iturria: Dialnet